| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | DE10248067A1 New N-diaminophenylpropyl- or N-heteroarylpropyl-piperazine or piperidine derivatives, useful as dopaminergic and/or serotoninergic agents for e.g. treating Parkinson's disease or schizophrenia |
| 04/14/2004 | EP0777656B1 Novel dna-targeted alkylating agents |
| 04/13/2004 | US6720349 Benzimidazole derivatives and salts and prodrugs thereof |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/08/2004 | WO2004010761A3 Pesticidal cyanine dye derivatives |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | US20040067997 Respiratory syncytial virus |
| 04/08/2004 | US20040067976 Compounds useful for treating Hepatitis C virus |
| 04/08/2004 | US20040067931 Benzimidazolidinone derivatives as muscarinic agents |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404659A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 04/07/2004 | EP1404656A1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 04/07/2004 | EP1404321A1 1-alkyl-2-aryl-benzimidazole derivatives, their use for producing medicaments and pharmaceutical preparations containing said derivatives |
| 04/07/2004 | EP0973512B1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 04/07/2004 | CN1486982A 2-phenyl benzoimidazole-5-sulfonic acid prepared with segregative 3.4-diaminobenzene sulfonic and its application in cosmetics production |
| 04/07/2004 | CN1486981A Prepn process of 2-chlorobenzimidazole |
| 04/07/2004 | CN1144790C Telmisartan polymorphs, producing process thereof and use in prepn. of pharmaceutical composition thereof |
| 04/06/2004 | US6716849 Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 04/06/2004 | US6716846 High affinity ligands for nociceptin receptor ORL-1 |
| 04/06/2004 | US6716840 Agonists of the melanocortin-4 receptor (?mc-4r?); useful treating obesity and type 2 diabetes |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026301A1 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands |
| 04/01/2004 | WO2004011439A3 Aryl substituted benzimidazoles and their use as sodium channel blockers |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063642 Novel benzimidazolone peptidomimetics as thrombin receptor antagonists |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 03/31/2004 | EP1403256A1 Fused imidazole derivative |
| 03/31/2004 | EP1402890A1 Sulfonamide derivatives |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1401452A1 Beta-hydroxyamine derivatives useful in the treatment of alzheimer's disease |
| 03/31/2004 | EP1401431A2 Human growth hormone antagonists |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/25/2004 | WO2004024721A1 Hydantoin derivatives und deren verwendung als tace inhibitoren |
| 03/25/2004 | WO2004024715A1 Sulphonamide derivatives and their use as tace inhibitors |
| 03/25/2004 | WO2004024699A1 Benzimidazolones and their use as cytokine inhibitors |
| 03/25/2004 | WO2003082186A3 Use of benzimidazole analogs in the treatment of cell proliferation |
| 03/25/2004 | WO2003069350A3 Small molecule modulators of apoptosis |
| 03/25/2004 | US20040059125 2-phenylbenzimidazole-5-sulphonic acid from isolated 3,4-diaminobenzenesulphonic acid and use thereof in cosmetic preparations |
| 03/25/2004 | US20040058972 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 03/25/2004 | US20040058934 Heterocyclic compounds |
| 03/25/2004 | US20040058933 Aryl carbamate derivatives, preperation and use thereof |
| 03/25/2004 | US20040058913 Cyclic diamine compound with condensed-ring groups |
| 03/25/2004 | DE10243027A1 2-Phenyl-benzimidazol-5-sulfonsäure aus isolierter 3,4-Diaminobenzol-sulfonsäure sowie deren Verwendung in kosmetischen Zubereitungen 2-phenyl-benzimidazole-5-sulfonic acid isolated from 3,4-diaminobenzene-sulfonic acid and their use in cosmetic formulations |
| 03/25/2004 | CA2497571A1 Hydantoin derivatives and their use as tace inhibitors |
| 03/24/2004 | EP1400517A2 2-Phenyl-1H-benzimidazole-5-sulfonic acid prepared from 3,4-Diaminobenzenesulfonacid and its use in the cosmetic compositions |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1400241A1 Fused cyclic compounds and medicinal use thereof |
| 03/24/2004 | EP1399416A2 Peptide deformylase inhibitors |
| 03/24/2004 | EP1197493B1 Benzimidazole compounds |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | CN1484638A I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands |
| 03/24/2004 | CN1484634A Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/23/2004 | US6710204 N-oxyl compound contained in an easily polymerizable material can be sufficiently decreased and loss of easily polymerizable material (acrylic or methacrylic acids or their esters) is little |
| 03/23/2004 | US6710065 Benzimidazole derivatives and their use for the treatment of cancer or a viral infection |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710044 Technical field |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022060A2 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 03/18/2004 | WO2004007459A3 Naphthol, quinoline and isoquinoline-derivatives as modulators of vanilloid vr1 receptor |
| 03/18/2004 | WO2003099266A3 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/18/2004 | WO2003020698A3 Protein tyrosine kinase inhibitors |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053890 Naphthalene derivatives |
| 03/18/2004 | CA2497979A1 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | CA2497827A1 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders |
| 03/17/2004 | EP1140802B1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
| 03/17/2004 | EP1117638B1 Biphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions |
| 03/17/2004 | CN1482120A Process for preparing S,Síõ-carbonyl disulfhydryl substituted five-membered heterocyclic compound |
| 03/16/2004 | US6706929 Reacting phenol with dimethyl carbonate in presence of 1,4-diazabicyclo(2.2.2)octane catalyst |
| 03/16/2004 | US6706746 Thiadiazolidin-2,4-dione compound |
| 03/16/2004 | US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole |
| 03/16/2004 | US6706285 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | US20040048797 Regulation of TNF-alpha |
| 03/11/2004 | US20040048774 Inhibitors of IMPDH enzyme |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1480451A Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703410 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |